Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
NCT Number: NCT05628129
Regular follow-up is essential to successful management of congenital ectopia lentis, but it is often ignored by parents in China.
With rapid economic development, there are increasing numbers of mobile phone users that allow for communication applications to be used in medical care.
The investigators aimed to assess the potential of the smartphone application assisted medical service to increase patient compliance in attendance of follow-up after congenital ectopia lentis treatment.
This study is active but is not currently recruiting participants.
Up to 18 year
All sexes
Interventional
Not applicable
Guangzhou, Guangdong, 510060, China
Congenital ectopia lentis is a rare ophthalmic disease that seriously harms the physical and mental health of patients. Surgery is the only definite treatment at present. However, severe visual impairment is common in congenital ectopia lentis patients in China, and delayed presentation to hospital and late surgical treatment are found to be the major reasons.
In China, the messaging application WeChat has become the most popular communication tool. As most congenital ectopia lentis patients' parents are younger people, they are more likely to use technology, such as WeChat, in their daily lives. In addition, it allows ophthalmologists to utilize this communication application to relay health related information and reminders to patients. This makes it feasible to apply this smartphone application in improving attendance of follow-up visits.
In this trial, the investigators aimed to assess the potential of the smartphone application assisted medical service to increase patient compliance in attendance of follow-up after congenital ectopia lentis treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
smartphone application service and phone reminder for appointments of parents of congenital ectopia lentis patients
Time frame: 3 months
the rates of attendance at 3 months (± 3 weeks) after surgery
Time frame: 1 week
the rates of attendance at 1 week (± 2 days) after surgery
Time frame: 1 month
the rates of attendance at 1 month (± 1 week) after surgery
Time frame: 3 months
measurement of best corrected visual acuity was carried out using a logarithm of the Minimum Angle of Resolution (logMAR) chart at the baseline and endline visits
Time frame: 3 months
If the difference between the current refraction and the currently worn eyeglass prescription was greater than 2 diopters sphere and/or greater than 1 diopter cylinder, a new prescription was given
Time frame: 3 months
the rate of amblyopia therapy during 3 months after surgery
Time frame: 3 months
referral rate due to abnormalities in skeletal system and cardiovascular system during 3 months after surgery
Time frame: 3 months
change between baseline and endline scores on knowledge about CEL, including six choice questions concerning pathogenesis, symptoms and treatment of CEL
Time frame: 6 months
the rates of attendance at 6 months (± 1 month) after surgery
Time frame: 1 year
the rates of attendance at 1 year (± 2 months) after surgery
Time frame: 2 years
the rates of attendance at 2 years (± 4 months) after surgery
Time frame: 3 years
the rates of attendance at 3 years (± 6 months) after surgery
Zhongshan Ophthalmic Center, Sun Yat-sen University
Other
Effect of WeChat Application Combined Phone Reminder on Follow-up Adherence Improvement in Congenital Ectopia Lentis Patients : A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07096622
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Guangzhou, Guangdong, China
View Trial DetailsNCT05654025
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Guangzhou, Guangdong, China
View Trial DetailsNCT04319107
Abnormalities, Multiple, Bone Diseases
Bron, France
View Trial DetailsNCT06545305
Amino Acid Metabolism, Inborn Errors, Brain Diseases
Jeddah, Saudi Arabia
View Trial Details